Credit Suisse initiated coverage on Vicarious Surgical with a new price target
$RBOT
Industrial Specialties
Health Care
Credit Suisse initiated coverage of Vicarious Surgical with a rating of Outperform and set a new price target of $16.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/4/2022 | $16.00 → $7.00 | Overweight → Neutral | Piper Sandler |
| 1/7/2022 | $16.00 | Outperform | Credit Suisse |
| 12/7/2021 | $15.00 | Outperform | Cowen & Co. |
| 11/5/2021 | $15.00 | Buy | Canaccord Genuity |
| 10/18/2021 | $15.00 | Buy | BTIG |
| 10/7/2021 | $16.00 | Overweight | Piper Sandler |